-
US Supreme Court rules against man whose dreadlocks were cut off in prison
-
American Michele Kang agrees deal to buy French club Lyon
-
UN to begin evacuating stranded Mideast sailors after US-Iran talks
-
French farmers suffer arid crops, heat-stricken animals
-
Tech drags down world stocks, oil dips on supply hopes
-
Scorching heat shuts Paris landmarks early as France swelters
-
Shootout traps tourists at Rio sunrise lookout
-
Ipswich hire Gary O'Neil as manager
-
Heatwave sparks health warnings across Europe
-
Lake wins Wales captaincy race ahead of Morgan
-
Hundreds of schools close as UK braces for record-breaking heatwave
-
Tech names drag down world stocks, oil dips on supply hopes
-
Starmer vows 'orderly' transition as Labour MPs mull bid to be PM
-
Reports of Dupont inclusion in France squad 'bordering on annoying' says Galthie
-
ACTIVIST SHAREHOLDER FILES SCHEDULE 13D IN EQUUS TOTAL RETURN, INC.
-
England coach McCullum denies rift with 'good friend' Stokes
-
Europe: the world's fastest-warming continent
-
Taliban officials hold EU migration talks in Brussels
-
Gennaro Gattuso returns to coaching with Lazio after Italy debacle
-
Kenya halts US Ebola facility: health minister tells court
-
Why the heat is wreaking havoc on Europe's trains
-
Zelensky to skip key Ukraine conference in Poland over WWII row
-
Seoul leads rout for tech shares as oil prices dip
-
Europe heatwave closes schools, threatens health
-
India monsoon sweeps north but brings less rain than usual
-
Germany eyes longer working lives in pension reform plan
-
UK and markets await Burnham's economic plans
-
Iran says won't allow UN inspectors at bombed nuclear sites
-
Heineken names new CEO after predecessor's shock departure
-
Banned Vondrousova insists she has 'never doped'
-
Schools plan to close as UK braces for record-breaking heatwave
-
UN chief urges AI firms to 'come clean' over environmental footprint
-
India startup head Kunal Shah appointed as new WhatsApp boss
-
More records set to fall as deadly Europe heatwave drags on
-
Israel's 'deliberate targeting' of children part of ongoing Gaza 'genocide': UN probe
-
England, Ghana eye last 32 as Portugal look for lift-off
-
Seoul's Kospi stock index tanks 10% to lead tech-fuelled Asia rout
-
Sri Lanka troops to battle deadly dengue mosquitoes as cases rise
-
Iran says to oversee Hormuz as Swiss talks conclude
-
Diaspora World Cup champions diversity over division
-
Guns, drones and doves: War reshapes Ukrainian jewellery scene
-
Australia withholds Pacific climate fund reports over risk of diplomatic 'damage'
-
Kenya police violence victims say compensation promise a 'smokescreen'
-
Indian startup head appointed as new WhatsApp boss
-
EU bets on digital euro to cut US tech addiction
-
Antetokounmpo joining Miami Heat in blockbuster: reports
-
Fineanganofo rethinks Newcastle move after All Blacks call-up
-
'Let's be realistic': Haaland cools Norway's World Cup expectations
-
Stocks fluctuate after Wall St sell-off, crude holds losses on peace talks
-
Lightning, downpour, a two-hour delay: bad weather hits the World Cup
CBDL Announces Strategic Rollout on Vibe Performance Network, Elevating 8000MG Pain Cream to National Streaming Audiences
CBD Life Sciences Inc. (OTC:CBDL) expands its digital advertising arsenal through the Vibe Performance Network, positioning its flagship 8000MG Pain Cream in front of millions of engaged, wellness-focused viewers - unlocking massive revenue potential and long-term shareholder value in the booming CBD market.
SCOTTSDALE, ARIZONA / ACCESS Newswire / July 8, 2025 / CBD Life Sciences Inc. (OTC:CBDL), parent company of CBD Vault, is thrilled to announce a transformational leap in its national marketing strategy through integration with Vibe, a cutting-edge self-serve streaming TV advertising platform. This strategic move empowers CBDL to deliver targeted, data-driven campaigns across top-tier streaming platforms including Hulu, ESPN+, Roku, Discovery+, Tubi, and dozens of other premium outlets.
As part of this rollout, CBDL will begin aggressively marketing its new 8000MG Pain Relief Cream - its most potent and in-demand product to date. Designed for athletes, chronic pain sufferers, and everyday individuals seeking fast, long-lasting relief, the 8000MG Pain Cream delivers unparalleled results - and now, it will reach a national audience with unmatched precision.
"This initiative represents one of the most important and scalable steps forward in CBDL's history," said Lisa Nelson, President & CEO of CBDL. "With Vibe, we're not just buying ad space - we're owning the channel to our core audience. This technology allows us to place the right product in front of the right person at the right time. That means greater efficiency, greater visibility, and greater returns."
The Vibe Advantage: Why This is a Major Inflection Point for CBDL
CBDL's integration with the Vibe Performance Network gives the company unprecedented access to millions of health-conscious consumers across the U.S., including targeted audiences based on:
Demographics (age, gender, income)
Behavioral habits and content interests
Zip-code level geographic targeting
Engagement with wellness, recovery, fitness, and CBD-related content
Unlike traditional TV or social media ads, Vibe campaigns are performance-optimized - allowing for real-time analytics, creative testing, and dynamic budget scaling, all while keeping advertising costs significantly lower than legacy platforms.
Projected Revenue Impact and Market Positioning
With this expanded visibility, CBDL is now positioned to unlock significant recurring revenue across both direct-to-consumer and wholesale channels. Based on historical customer conversion data and industry benchmarks, the 8000MG Pain Cream campaign alone could drive a projected 7-figure boost in annual revenue, with the potential to scale beyond as CBD Vault's product line continues to grow.
This launch directly supports the company's mission of becoming a nationally recognized leader in natural wellness solutions, while laying the groundwork for future product launches using the same Vibe infrastructure.
The global CBD market is forecasted to exceed $22 billion by 2030, and topical CBD products - like pain creams - are expected to see the highest CAGR within the industry at over 32.1% annually, according to Grand View Research.
CBDL's powerful combination of product efficacy, consumer trust, and now digital ad precision, gives the company a major competitive edge as it scales nationwide.
Investor Significance
For current and prospective investors, this strategic deployment represents a material turning point in how the company markets, sells, and scales. By implementing a scalable, intelligent advertising ecosystem, CBDL is no longer reliant on outdated, inefficient marketing tactics - instead embracing the same programmatic tools used by Fortune 500 brands, tailored for the cannabis and wellness space.
In essence, CBDL now controls its own national media pipeline, giving the company the ability to:
Increase customer acquisition at lower costs
Expand brand awareness across multiple demographics
Support higher margins and longer customer lifetime value
Launch future products into an already-primed national audience
"This is more than just a campaign - it's infrastructure," added Nelson. "It's a system that can be used again and again to take new products to market, drive sales, and fuel consistent growth. It's a future-proof marketing engine."
Vibe Platform Website : https://www.vibe.co/

About CBD Life Sciences Inc. (CBDL)
CBD Life Sciences Inc. is an innovative health and wellness company committed to the research, development, and distribution of premium cannabidiol (CBD) products through its core brand, CBD Vault. From topicals and tinctures to wellness beverages and skincare solutions, CBDL is building a portfolio of products designed for maximum efficacy, transparency, and consumer trust.
Follow our social media for the latest updates!
X: https://www.x.com/CBDL_StockOTC
Instagram: https://www.instagram.com/cbd.vault
IR Contact: [email protected]
Stay Connected & Be the First to Try Our New Functional Mushroom Products!
Mushroom Madness Instagram: https://www.instagram.com/mushroom.madnessaz
Mushroom Madness Website: https://www.mushroommadness.shop
Forward-Looking Statements
Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements. Actual results may differ materially from those described in forward-looking statements and are subject to risks and uncertainties. See CBD Life Sciences, Inc's, Inc.'s filings with OTC Markets, which may identify specific factors that may cause actual results or events to differ materially from those described in the forward-looking statements.
Safe Harbor Statement
This release includes forward-looking statements, which are based on certain assumptions and reflects management's current expectations. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Some of these factors include: general global economic conditions; general industry and market conditions, sector changes and growth rates; uncertainty as to whether our strategies and business plans will yield the expected benefits; increasing competition; availability and cost of capital; the ability to identify and develop and achieve commercial success; the level of expenditures necessary to maintain and improve the quality of services; changes in the economy; changes in laws and regulations, including codes and standards, intellectual property rights, and tax matters; or other matters not anticipated; our ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking ability to secure and maintain strategic relationships and distribution agreements. The Company disclaims any intention or obligation to update or revise any forward-looking statements.
Contact Information
Lisa Nelson
CEO
[email protected]
4802091720
SOURCE: CBD Life Sciences, Inc.
View the original press release on ACCESS Newswire
M.White--AT